ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

42
Analysis
Health Care • China
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
•13 Nov 2015 17:14

Quick Note - Almost at the Finishing Line

Latest Update:Glass Lewis and ISS have advised Wuxi's shareholders to approve the offer from the consortium. We believe Shareholders will vote in...

Share
•05 Nov 2015 20:23

Mindray - 2 Steps back 1 Step forward

Mindray Medical International Limited ("Mindray") has announced that it has entered into a definitive Agreement with Excelsior Union Limited...

Share
•13 Sep 2015 11:02

Buyout Offer Lowered to US$27/ADS from US$30/ADS

Mindray's management team has lowered its buyout offer by 10% to US$27/ADS, citing 1) the company's recent poor financial performance, 2)...

Share
•05 Sep 2015 02:01

A Buyout Offer That Needs Improvement

iKang Healthcare Group, China's largest private preventive healthcare services provider, has received a preliminary proposal from its founder,...

Share
•17 Jul 2015 01:01

WuXi PharmaTech: How to Argue for a Few Dollars More

WuXi PharmaTech's recent placements of stock of its NEEQ-listed Syn-The-All Pharmaceutical Co. subsidiary have been at a substantially higher...

Share
x